CAMKK2 and autosomal dominant polycystic kidney disease: Using genetic and pharmacological approaches, we showed that CaMK4 is an important regulator of mTOR-mediated proliferation of human ADPKD cells and that inhibition of CaMK4 or its upstream regulators CaM and CaMKKβ significantly reduced mTOR signaling.